# EQT Life Sciences: portfolio, investments and team

> EQT Life Sciences is a vc firm based in Netherlands. 60 investments on record, 16 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/eqt-life-sciences (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Investor](https://millionrounds.com/investors)

# EQT Life Sciences

Last cheque observed Oct 2026; 60 cheques on record.

Email

Deploying now VC firm

Series A Series B Growth Venture Capital & Private Equity

Follow EQT Life Sciences and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Feqt-life-sciences)

Deploying now

**80%** of best year **16** **cheques in 12 months**, 60 on record

Since the last cheque **12** days **00** hrs **00** min **00** sec

Median round **$50M** Rounds led **2 of 60** Sole investor **3 rounds** Mostly in **Netherlands, 20%**

Pitch EQT Life Sciences

## EQT Life Sciences highlights

- 01 16 cheques in the last 12 months
- 02 Mostly Series B and Series A: 56% of its rounds
- 03 Sole investor in 3 rounds, median $57M

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Series A Series B Growth
- **Sectors:** Venture Capital & Private Equity
- **Based in:** Amsterdam, Netherlands
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **60 appearances**

- **2026** 14 rounds
- **Oct** **[Nouscom](https://millionrounds.com/company/nouscom)** Series D · CH · Revelation Partners **$135M** With 14 others
- **Sept** **[Neurent Medical](https://millionrounds.com/company/neurent-medical)** Debt · IE · Claret Capital Partners **$29M** With 6 others
- **Sept** **[AstronauTx](https://millionrounds.com/company/astronautx)** Grant · GB **$1.2M** With 2 others
- **Aug** **[Vaderis Therapeutics](https://millionrounds.com/company/vaderis-therapeutics)** Series B · CH · Firms' own news pages **$152M** With 8 others
- **Jul** **[Xeltis](https://millionrounds.com/company/xeltis)** NL · Ysios Capital **$23M** With 5 others
- **Jun** **[RQ Bio](https://millionrounds.com/company/rq-bio)** Series A · GB · Frazier Life Sciences **$115M** With 7 others
- **Apr** **[Onward](https://millionrounds.com/company/onward)** NL **$48M** With 1 other
- **Mar** **[AviadoBio](https://millionrounds.com/company/aviadobio)** Venture · GB **Undisclosed** With 1 other
- **Mar** **[Egle Therapeutics](https://millionrounds.com/company/egle-therapeutics)** Grant · FR **$9.4M** With 2 others
- **Feb** **[Evommune](https://millionrounds.com/company/evommune)** US **$125M** With 5 others
- **Jan** **[Exciva](https://millionrounds.com/company/exciva)** Series B · DE **$59M** With 1 other
- **Jan** **[Tenpoint Therapeutics](https://millionrounds.com/company/tenpoint-therapeutics)** Debt · GB **$150M** With 4 others
- **Jan** **[ViCentra](https://millionrounds.com/company/vicentra)** Series D · NL **$13M** With 1 other
- **Jan** **[Kinaset Therapeutics](https://millionrounds.com/company/kinaset-therapeutics)** Series B · US **$103M** With 3 others
- **2025** 17 rounds
- **Dec** **[FoRx Therapeutics](https://millionrounds.com/company/forx-therapeutics)** Series A · CH **$50M** With 1 other
- **Nov** **[Artios Pharma](https://millionrounds.com/company/artios-pharma)** Series D · GB **$115M** With 5 others
- **Oct** **[Onward](https://millionrounds.com/company/onward)** NL **$58M** With 2 others
- **Oct** **[Tubulis](https://millionrounds.com/company/tubulis)** Series C · DE **$401M** With 4 others
- **Sept** **[ViCentra](https://millionrounds.com/company/vicentra)** Growth · NL · Silicon Canals **$85M** With 4 others
- **Aug** **[Cyted](https://millionrounds.com/company/cyted)** Series B · GB **$44M** With 3 others
- **Aug** **[SNIPR](https://millionrounds.com/company/snipr)** Series B · DK · Firms' own news pages **$41M** With 5 others
- **Jul** **[Neuros Medical](https://millionrounds.com/company/neuros-medical)** Series D · US **$56M** With 1 other
- **Jun** **[Mosanna Therapeutics](https://millionrounds.com/company/mosanna-therapeutics)** Series A · CH · Silicon Canals **$80M** *Led*
- **Jun** **[Splice Bio](https://millionrounds.com/company/splice-bio)** Series B · ES **$135M** With 2 others
- **Apr** **[Avidicure](https://millionrounds.com/company/avidicure)** Seed · NL **$50M** With 2 others
- **Apr** **[Xilis](https://millionrounds.com/company/xilis)** Venture · US **$19M** With 5 others
- **Mar** **[Perfuze](https://millionrounds.com/company/perfuze)** Growth · IE · Seroba Life Sciences **$24M** *Led*
- **Feb** **[XyloCor Therapeutics](https://millionrounds.com/company/xylocor-therapeutics)** Series B · US · Crunchbase News **$68M** With 2 others
- **Feb** **[DNA Script](https://millionrounds.com/company/dna-script)** Grant · FR **$4.7M** With 5 others
- **Feb** **[VarmX](https://millionrounds.com/company/varmx)** Venture · NL **$16M** With 1 other
- **Jan** **[Atalanta Therapeutics](https://millionrounds.com/company/atalanta-therapeutics)** Series B · US **$97M** With 1 other
- **2024** 12 rounds
- **Dec** **[Noema Pharma](https://millionrounds.com/company/noema-pharma)** Series B · CH **$147M** With 3 others
- **Dec** **[NUA Surgical](https://millionrounds.com/company/nua-surgical)** Series A · IE **$6.9M** With 2 others
- **Nov** **[ATB Therapeutics](https://millionrounds.com/company/atb-therapeutics)** Series A · BE **$57M** Sole investor
- **Oct** **[AgomAb Therapeutics](https://millionrounds.com/company/agomab-therapeutics)** Series D · BE **$89M** With 4 others
- **Oct** **[AviadoBio](https://millionrounds.com/company/aviadobio)** Venture · GB **$20M** With 1 other
- **Sept** **[Pantera](https://millionrounds.com/company/pantera)** Series A · US **$110M** With 4 others
- **Aug** **[ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics)** Grant · FR **$22M** With 6 others
- **Aug** **[Shinobi Therapeutics](https://millionrounds.com/company/shinobi-therapeutics)** Series A · US **$68M** With 2 others
- **Jun** **[Vico Therapeutics](https://millionrounds.com/company/vico-therapeutics)** Series B · NL · Seroba Life Sciences **$12M** With 12 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **8 named**

BE **Barry Eamon Breen** Chief Compliance Officer i Form ADV

BM **Brian Michael Fogarty** Director i Form ADV

HS **Henry Steinberg** Director, President i Form ADV

JP **John Peter Lloyd** Director, Chief Financial Officer i Form ADV

JN **Josefin Nowen Wirkkala** Director i Form ADV

MJ **Matthew Joseph Brodnick** Director, Chief Investment Officer i Form ADV

PJ **Patrick John Cordes** Director i Form ADV

PS **Piyush Singhvi** Director i Form ADV

We also hold **5** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$51B** assets it manages, 2 advisers combined Oct 2026

**8+** funds on file numbered funds in its name

**Registered** investment adviser full reporting to the SEC

- **Legal name:** EQT REAL Estate, LLC
- **SEC number:** CRD 161935

Funds on its Form ADV

**13** private funds, **$17B** in gross assets · filed Oct 2024

- Exeter Industrial Value Fund V, L.P. *Real estate* 60 investors $5.7B
- Exeter Industrial Core Fund III, L.P. *Real estate* $2.9B
- Exeter Europe Industrial Core Fund S.c.sp. *Real estate* 7 investors $2.0B
- EQT Exeter Industrial Core-Plus Fund IV L.P. *Real estate* 6 investors $2.0B
- Exeter Core Industrial CLUB Fund II, L.P. *Real estate* 10 investors $1.8B
- Exeter Europe Logistics Value Fund IV, S.c.sp. *Real estate* 36 investors $1.5B
- EQT Exeter Industrial Value Fund VI, L.P. *Real estate* 77 investors $987M
- Exeter Industrial Value Fund IV, L.P. *Real estate* 51 investors $170M
- Exeter Office Value Fund, L.P. *Real estate* 3 investors $113M
- EM P28 Opportunities Fund, L.P. *Real estate* 26 investors $107M

And 3 more on the filing.

## The cheque

Series A Series B Growth

Median round joined **$50M** the round, not its cheque Alone, median **$57M**

Led 2 of 60 rounds **3%**

- **Sole investor:** 3 rounds
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series B said *15*
- Series A said *13*
- Series D *7*
- Venture *6*
- Series C *5*
- Grant *4*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Andera Partners](https://millionrounds.com/fund/andera-partners) 13
- [EQT](https://millionrounds.com/fund/eqt) 7
- [Bpifrance](https://millionrounds.com/fund/bpifrance) 6
- [EIC Accelerator](https://millionrounds.com/fund/eic-accelerator) 6
- [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) 6
- [KurmaPartners](https://millionrounds.com/fund/kurmapartners) 5

**Pitching EQT Life Sciences?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as EQT Life Sciences. A count of rooms they were both in, not a relationship either has claimed.

[**Andera Partners** Private equity **13** rounds together](https://millionrounds.com/fund/andera-partners)[**EQT** Private equity **7** rounds together](https://millionrounds.com/fund/eqt)[**Bpifrance** Government **6** rounds together](https://millionrounds.com/fund/bpifrance)[**EIC Accelerator** Government **6** rounds together](https://millionrounds.com/fund/eic-accelerator)[**Sofinnova Partners** VC firm **6** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**KurmaPartners** VC firm **5** rounds together](https://millionrounds.com/fund/kurmapartners)[**Wellington Partners** VC firm **5** rounds together](https://millionrounds.com/fund/wellington-partners)[**Earlybird Venture Capital** VC firm **4** rounds together](https://millionrounds.com/fund/earlybird)[**Enterprise Ireland** Government **4** rounds together](https://millionrounds.com/fund/enterprise-ireland)[**RA Capital Management** Private equity **4** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Sanofi** Investment firm **4** rounds together](https://millionrounds.com/fund/sanofi)[**5AM Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/5am-ventures)

## Recently backed

The latest companies EQT Life Sciences put money into.

[**Nouscom** $135M · Oct 2026](https://millionrounds.com/company/nouscom)[**Neurent Medical** $29M · Sept 2026](https://millionrounds.com/company/neurent-medical)[**AstronauTx** $1.2M · Sept 2026](https://millionrounds.com/company/astronautx)[**Onward** $48M · Apr 2026](https://millionrounds.com/company/onward)[**AviadoBio** Mar 2026](https://millionrounds.com/company/aviadobio)[**Egle Therapeutics** $9.4M · Mar 2026](https://millionrounds.com/company/egle-therapeutics)

## Quick answers about EQT Life Sciences

### What does EQT Life Sciences invest in?

EQT Life Sciences invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Venture Capital & Private Equity.

### How active is EQT Life Sciences?

60 investments on record, 16 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.

### What has EQT Life Sciences invested in recently?

Its most recent investments on record: Nouscom (Series D, Oct 2026), Neurent Medical (Debt, Sept 2026) and AstronauTx (Grant, Sept 2026).

### How big are EQT Life Sciences's cheques?

The median round it joins is $50M.

### Does EQT Life Sciences lead rounds?

Sometimes: it led 2 of its 60 investments on record (3%).

### Where does EQT Life Sciences invest?

Most of the companies it backs are in the Netherlands (20%), the United States (20%) and the United Kingdom (18%).

### Is EQT Life Sciences investing now?

Yes: it is actively investing, with 16 investments in the last 12 months.

### Who does EQT Life Sciences invest alongside?

Most often Andera Partners (13 rounds together), EQT (7 rounds together) and Bpifrance (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=eqt-life-sciences) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=eqt-life-sciences)